• Explore /
  • Poster
  • / Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment: The CARACAS study.

Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment: The CARACAS study.

Abstract Video & Slides Poster

Authors

Sara Lonardi

Sara Lonardi

Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy

Sara Lonardi , Filippo Pietrantonio , Alessandra Anna Prete , Marco Messina , Nicola Renzi , Domenico C. Corsi , Federica Urbano , Giovanni Luca Frassineti , M. Giulia Zampino , Monica Ronzoni , Mario Scartozzi , Mariaelena Casagrande , Alessandra Boccaccino , Francesca Bergamo , Michele Prisciandaro , Cosimo Rasola , Salvatore Corallo , Paola Del Bianco , Valentina Vettore , Vittorina Zagonel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Anal Cancer

Clinical Trial Registration Number

NCT03944252

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4051)

DOI

10.1200/JCO.2020.38.15_suppl.4051

Abstract #

4051

Poster Bd #

43

Abstract Disclosures

Similar Posters

First Author: Alessandra Anna Prete

First Author: Shipra Gandhi

First Author: Veronica Conca

First Author: Xavier Garcia del Muro